Straits Times Index
3,247.76 -35.59 (-1.08%) S&P 500
4,385.19 -24.94 (-0.57%) Dow
34,408.28 +43.78 (+0.13%) Nasdaq
13,680.77 -174.36 (-1.26%) BTC-USD
36,969.41 +952.87 (+2.65%) CMC Crypto 200
841.58 +20.99 (+2.56%)
Valneva SE (VALN)
- Zacks
Valneva (VALN) Up as COVID-19 Jab Neutralizes Omicron Variant
Three doses of Valneva's (VALN) inactivated COVID-19 vaccine candidate, VLA2001, neutralizes the Omicron variant of SARS-CoV-2, per data from preliminary lab studies. Shares rally.
- Reuters
Shares in COVID-19 vaccine developer Valneva extend fall
Shares in biotech company Valneva fell again on Wednesday, declining for the seventh day in a row due to a growing belief amongst investors that the COVID-19 Omicron variant might lessen the need for mass vaccination. At 0945 GMT, Valneva shares were down 3% at 17.10 euros, meaning the stock has now lost close to 40% since its Dec. 27 close of 26.38 euros. It did gain more than 200% a year in 2021 and 2020 as Valneva's COVID-19 vaccine candidate came increasingly closer to approval.
- Motley Fool
Is This New Data on Valneva's Less-Effective Booster Concerning?
Some recent dismal results for Valneva's vaccine looked bad. But there could be more to the story.
